AbbVie
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AbbVie and other ETFs, options, and stocks.About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
ABBV Key Statistics
ABBV News
Truist analyst Srikripa Devarakonda lowered the firm’s price target on AbbVie (ABBV) to $211 from $215 and keeps a Buy rating on the shares as part of a broader...
In a regulatory filing, AbbVie (ABBV) stated, “Reported GAAP earnings and adjusted non-GAAP earnings for the fourth quarter of 2024 are expected to include acqu...
AbbVie (NYSE:ABBV) said it now expects to report acquired IPR&D and milestone expenses of $1.6B on a pre-tax basis for Q4, which will lower GAAP and non-GAAP ea...
Analyst ratings
61%
of 31 ratingsMore ABBV News
Some prominent healthcare and consumer stocks have fallen out of favor with the market, so now is the time to pounce on some great deals. Want to make a lot of...
The board of AbbVie Inc. ( ) has announced that it will be paying its dividend of $1.64 on the 14th of February, an increased payment from last year's comparabl...
